tm logo

Monitor this mark

View On USPTO

VIDAZA
Live/Registered
REGISTERED AND RENEWED

on 03 Jun 2024

Last Applicant/ Owned by

Celgene Corporation

86 Morris Avenue

Summit

NJ

07901

Serial Number

78138324 filed on 24th Jun 2002

Registration Number

2928231 registered on 22nd Feb 2005

in the Principal Register

Correspondent Address

Marilyn F. Kelly

Marilyn F. Kelly Bristol-Myers Squibb Company

Trademark Dept., Mailstop D.4243

PRINCETON, NJ 08648

United States

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

VIDAZA

Pharmaceutical preparations for the treatment of blood disease and cancer

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for the treatment of blood disease and cancer

First Use Date in General

31st Jul 2004

First Use Date in Commerce

31st Jul 2004

Mark Details

Serial Number

No 78138324

Mark Type

No Service/Collective Mark

Attorney Docket Number

No CELG0490US

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
03rd Jun 2024REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
03rd Jun 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
03rd Jun 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
31st May 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
22nd Feb 2024TEAS SECTION 8 & 9 RECEIVED
22nd Feb 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
09th Dec 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09th Dec 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
09th Dec 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
09th Dec 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED